BTIG Research Assumes Bruker Corporation to Neutral

Brokerage firm BTIG Research Assumes its rating on Bruker Corporation(NASDAQ:BRKR). The shares have been rated Neutral. The rating by BTIG Research was issued on Jul 22, 2016.

In a different note, On May 5, 2016, BTIG Research said it Downgrades its rating on Bruker Corporation. The shares have been rated ‘Neutral’ by the firm. On May 5, 2016, Leerink Swann said it Maintains its rating on Bruker Corporation. In the research note, the firm Raises the price-target to $27.00 per share. The shares have been rated ‘Market Perform’ by the firm.

Bruker Corporation (BRKR) made into the market gainers list on Thursdays trading session with the shares advancing 0.29% or 0.07 points. Due to strong positive momentum, the stock ended at $24.48, which is also near the day’s high of $24.53. The stock began the session at $24.34 and the volume stood at 5,15,756 shares. The 52-week high of the shares is $29.85 and the 52 week low is $15.778. The company has a current market capitalization of $3,952 M and it has 16,14,54,760 shares in outstanding.

Bruker Corporation(BRKR) last announced its earnings results on May 4, 2016 for Fiscal Year 2016 and Q1.Company reported revenue of $375.40M. Analysts had an estimated revenue of $360.37M. Earnings per share were $0.21. Analysts had estimated an EPS of $0.15.

Several Insider Transactions has been reported to the SEC. On Jun 15, 2016, Frank H Laukien (CEO) purchased 4,174 shares at $23.95 per share price.Also, On Jun 7, 2016, Joerg C Laukien (director 10% owner) sold 2,000,000 shares at $25.65 per share price.On May 11, 2016, Brenda J Furlong (director) sold 22,600 shares at $27.43 per share price, according to the Form-4 filing with the securities and exchange commission.

Bruker Corporation is a designer and manufacturer of life science and materials research systems and associated products that address the needs of a range of customers in life science research pharmaceuticals applied markets nanotechnology cell biology clinical research microbiology and in-vitro diagnostics. The Company operates through two segments: Bruker Scientific Instruments (BSI) and Bruker Energy & Supercon Technologies (BEST). BSI is organized into three operating segments: the Bruker BioSpin Group the Bruker CALID Group and the Bruker Nano Group. BEST designs manufactures and distributes superconducting materials. The company maintains technical and manufacturing centers in Europe and North America and it has sales offices located throughout the world.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Bruker Corporation - Is it time to Sell?

Top Brokerage Firms are advising their investors on Bruker Corporation. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.